Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432

Eur J Dermatol. 2018 Aug 1;28(4):520-521. doi: 10.1684/ejd.2018.3318.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Fatal Outcome
  • Hemangiosarcoma / complications
  • Hemangiosarcoma / secondary
  • Hemangiosarcoma / therapy*
  • Hemothorax / etiology
  • Hemothorax / therapy
  • Humans
  • Male
  • Paclitaxel / administration & dosage*
  • Picibanil / administration & dosage*
  • Pleural Neoplasms / complications
  • Pleural Neoplasms / secondary
  • Pleural Neoplasms / therapy*
  • Pleurodesis*
  • Pneumothorax / etiology
  • Pneumothorax / therapy
  • Recurrence
  • Skin Neoplasms / pathology*

Substances

  • Antineoplastic Agents
  • Picibanil
  • Paclitaxel